ACA
TMO icon

Atlas Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Atlas Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230K Buy
467
+130
+39% +$70.6K 0.03% 388
2025
Q4 		$195K Buy
+337
New +$191K 0.02% 424
2025
Q2 		$282K Sell
695
-52
-7% -$21.7K 0.03% 343
2025
Q1 		$372K Hold
747
– – 0.05% 305
2024
Q4 		$389K Hold
747
– – 0.05% 291
2024
Q3 		$462K Hold
747
– – 0.07% 236
2024
Q2 		$413K Sell
747
-100
-12% -$57.3K 0.05% 259
2024
Q1 		$492K Hold
847
– – 0.08% 220
2023
Q4 		$450K Sell
847
-50
-6% -$24.2K 0.07% 239
2023
Q3 		$454K Hold
897
– – 0.07% 204
2023
Q2 		$468K Buy
897
+375
+72% +$202K 0.07% 210
2023
Q1 		$301K Hold
522
– – 0.05% 282
2022
Q4 		$287K Buy
522
+75
+17% +$39.7K 0.05% 268
2022
Q3 		$227K Hold
447
– – 0.04% 324
2022
Q2 		$243K Hold
447
– – 0.04% 340
2022
Q1 		$264K Buy
447
+70
+19% +$40.2K 0.04% 304
2021
Q4 		$252K Hold
377
– – 0.04% 325
2021
Q3 		$215K Hold
377
– – 0.03% 333
2021
Q2 		$190K Buy
377
+12
+3% +$5.66K 0.03% 364
2021
Q1 		$167K Hold
365
– – 0.03% 349
2020
Q4 		$170K Buy
+365
New +$171K 0.04% 322
2020
Q3 		– Sell
-365
Closed -$132K – 569
2020
Q2 		$132K Hold
365
– – 0.03% 362
2020
Q1 		$104K Sell
365
-160
-30% -$50.5K 0.03% 358
2019
Q4 		$171K Hold
525
– – 0.04% 333
2019
Q3 		$153K Sell
525
-200
-28% -$57.3K 0.05% 358
2019
Q2 		$213K Sell
725
-150
-17% -$41.3K 0.07% 283
2019
Q1 		$240K Sell
875
-48
-5% -$11.9K 0.09% 240
2018
Q4 		$207K Buy
923
+48
+5% +$11.3K 0.08% 252
2018
Q3 		$216K Hold
875
– – 0.07% 282
2018
Q2 		$185K Buy
875
+325
+59% +$69K 0.07% 279
2018
Q1 		$114K Buy
+550
New +$115K 0.03% 329

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Atlas Capital Advisors's TMO Position: Q1 2026 in Review

Atlas Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 39% in Q1 2026, buying an estimated $70.6K and bringing the position to 467 shares worth $230K. The position accounts for 0.03% of the portfolio, ranked #388.

Atlas Capital Advisors first reported a position in TMO in Q1 2018 and has held it in 31 quarters since. The position peaked at $492K in Q1 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Atlas Capital Advisors held 467 shares of Thermo Fisher Scientific worth $230K as of Q1 2026.
  • Atlas Capital Advisors bought 130 Thermo Fisher Scientific shares in Q1 2026, an estimated $70.6K.
  • Thermo Fisher Scientific made up 0.03% of Atlas Capital Advisors's portfolio in Q1 2026, its #388 holding.
  • Atlas Capital Advisors first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 31 quarters since.
  • Atlas Capital Advisors's Thermo Fisher Scientific position peaked at $492K in Q1 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Atlas Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.